Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

502
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
502
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

401
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

453
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
453
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

4.0K
The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
4.0K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of resveratrol on endothelial progenitor cells and apoptosis biomarkers in postmenopausal women with chronic coronary heart disease: a randomized controlled trial.

Frontiers in nutrition·2026
Same author

Kounis Syndrome Type II after Diclofenac Exposure: Unmasking a Link Between Drug Allergy and Acute Coronary Syndrome.

Arquivos brasileiros de cardiologia·2026
Same author

Can Vaccination Prevent the Development of Chagas Disease Cardiomyopathy?

JACC. Basic to translational science·2026
Same author

7-Ketocholesterol Links Sterol Homeostasis to Hedgehog Signaling and Stress-Survival Responses in MSCs from Patients with Acute Myeloid Leukemia.

International journal of molecular sciences·2026
Same author

An innovative nasal nanovaccine against SARS-CoV-2 induces systemic and upper airway immunity controlling viral replication.

NPJ vaccines·2026
Same author

Reversal of Left Bundle Branch Block Following Treatment in Alcoholic Cardiomyopathy.

Arquivos brasileiros de cardiologia·2025
Same journal

From Cardioprotection to Trial Design: Rethinking Cardiac Safety in Oncology.

Current heart failure reports·2026
Same journal

Acute and Chronic Myocarditis in Men and Women.

Current heart failure reports·2026
Same journal

Smart Technology, Fragile Hearts: Navigating AI's Challenges and Limitations in Heart Failure Management.

Current heart failure reports·2026
Same journal

Palliative Care in Advanced Heart Failure.

Current heart failure reports·2026
Same journal

The Evolving Utility of Artificial Intelligence-Based Tools for the Detection of Heart Failure and Cardiomyopathies: From Potential to Implementation.

Current heart failure reports·2026
Same journal

Emerging Artificial Intelligence Tools for the Screening of Structural and Valvular Heart Disease.

Current heart failure reports·2026
See all related articles

Related Experiment Video

Updated: Jan 15, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.6K

Sex Differences in Chagas Cardiomyopathy: a Comprehensive Review.

Antonio de Padua Mansur1, Edecio Cunha-Neto2,3, Reinaldo Bulgarelli Bestetti4

  • 1Serviço de Prevencao, Cardiopatia na Mulher e Reabilitação Cardiovascular, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil. apmansur@yahoo.com.

Current Heart Failure Reports
|October 13, 2025
PubMed
Summary
This summary is machine-generated.

Men with Chagas cardiomyopathy experience severe heart failure (HF) more often. Women show milder HF phenotypes and slower progression, suggesting a need for sex-specific Chagas cardiomyopathy management.

Keywords:
Chagas cardiomyopathyCytokinesFibrosisHeart failureSex characteristicsTh1 cells

More Related Videos

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.7K
Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

2.0K

Related Experiment Videos

Last Updated: Jan 15, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.6K
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.7K
Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

2.0K

Area of Science:

  • Cardiology
  • Immunology
  • Genetics

Background:

  • Chagas cardiomyopathy (CCC) is a primary cause of heart failure (HF) in Latin America.
  • Sex-specific differences in HF presentation and outcomes in CCC are not well understood.

Purpose of the Study:

  • To review current knowledge on clinical manifestations, HF phenotypes, and molecular mechanisms in women and men with CCC.
  • To highlight sex-based disparities in Chagas cardiomyopathy.

Main Methods:

  • Literature review of clinical manifestations, HF phenotypes, and molecular mechanisms in CCC.
  • Analysis of sex-specific differences in disease presentation, progression, and molecular signatures.

Main Results:

  • Men with CCC more frequently present with severe HF, arrhythmias, and sudden cardiac death.
  • Women with CCC often exhibit milder HF phenotypes, slower progression, and varied HF subtypes (HFrEF, HFmrEF, HFpEF).
  • Molecular studies reveal distinct inflammatory profiles: males show Th1 signatures, while females exhibit Th2 and Treg enrichment.

Conclusions:

  • Significant sex-based differences exist in CCC presentation, HF phenotypes, and underlying molecular mechanisms.
  • Hormonal and immune factors may contribute to milder disease progression in women.
  • Sex-specific evaluation and management strategies are crucial for optimizing CCC care.